"Aged" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.
Descriptor ID |
D000368
|
MeSH Number(s) |
M01.060.116.100
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged".
Below are MeSH descriptors whose meaning is more specific than "Aged".
This graph shows the total number of publications written about "Aged" by people in this website by year, and whether "Aged" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 35 | 35 |
1996 | 0 | 37 | 37 |
1997 | 0 | 55 | 55 |
1998 | 0 | 47 | 47 |
1999 | 0 | 19 | 19 |
2000 | 0 | 56 | 56 |
2001 | 0 | 70 | 70 |
2002 | 0 | 97 | 97 |
2003 | 0 | 85 | 85 |
2004 | 2 | 85 | 87 |
2005 | 0 | 99 | 99 |
2006 | 0 | 97 | 97 |
2007 | 0 | 116 | 116 |
2008 | 2 | 119 | 121 |
2009 | 0 | 138 | 138 |
2010 | 0 | 156 | 156 |
2011 | 0 | 180 | 180 |
2012 | 0 | 205 | 205 |
2013 | 0 | 190 | 190 |
2014 | 0 | 185 | 185 |
2015 | 1 | 195 | 196 |
2016 | 0 | 257 | 257 |
2017 | 0 | 276 | 276 |
2018 | 0 | 227 | 227 |
2019 | 0 | 264 | 264 |
2020 | 0 | 226 | 226 |
2021 | 0 | 161 | 161 |
2022 | 0 | 68 | 68 |
2023 | 0 | 36 | 36 |
2024 | 0 | 105 | 105 |
2025 | 0 | 7 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged" by people in Profiles.
-
Depression and Incident Hypertension: The Strong Heart Family Study. Prev Chronic Dis. 2025 Jan 16; 22:E06.
-
National survey of financial burden and experience among patients with cancer and autoimmune disease receiving charitable copay assistance. Cancer. 2025 Jan 15; 131(2):e35721.
-
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer. J Immunother Cancer. 2025 Jan 11; 13(1).
-
Financial Toxicity in Older Adults With Cancer and Their Caregivers. JCO Oncol Pract. 2025 Jan; 21(1):92-99.
-
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. Nat Commun. 2025 Jan 09; 16(1):553.
-
Rehabilitation at Home Using Mobile Health for Older Adults Hospitalized for Ischemic Heart Disease: The RESILIENT Randomized Clinical Trial. JAMA Netw Open. 2025 Jan 02; 8(1):e2453499.
-
A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers. Cancer. 2025 Jan 01; 131(1):e35680.
-
Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Breast Cancer Res. 2024 Dec 30; 26(1):191.
-
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U. JCO Precis Oncol. 2024 Dec; 8:e2400327.
-
COVID-19 Exacerbates Neurovascular Uncoupling and Contributes to Endothelial Dysfunction in Patients with Mild Cognitive Impairment. Biomolecules. 2024 Dec 18; 14(12).